That equates to a halving in price every year for two decades. It puts Moore’s Law to shame. If the price-performance improvements in genome sequencing had followed the same curve as Moore’s predictions for microchips, at the time of writing you could expect to pay more than $100,000 per sequence. In fact, genome sequencing has fallen 1,000 times further than Moore’s Law would have forecast.
